COMMUNIQUÉS West-GlobeNewswire

Sharps Technology Announces Reverse Stock Split

24/04/2025 - 17:00

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart- [...]

Best Dental Implants in Seattle Done by Dr. Javadi

24/04/2025 - 17:30

Dr. Javadi Successfully Places Dental Implants Using CT Guidance SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics & Dental [...]

PCI Biotech Holding ASA: Annual Report 2024

24/04/2025 - 17:31

Oslo, Norway, April 24, 2025 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2024. Please find the report attached, as well as the report according to the European Single Electronic [...]

Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025

24/04/2025 - 17:33

Une nouvelle technologie d’IA pour améliorer la précision des biopsies de la prostate et l’efficacité des procédures GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou [...]

GUERBET: Chiffre d’affaires du 1er trimestre 2025

24/04/2025 - 17:45

Chiffre d’affaires du 1 er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC 1 et périmètre comparable 2 Comme anticipé, un premier trimestre marqué par un impact France [...]

Guerbet: Q1 2025 revenue

24/04/2025 - 17:45

Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER 1 and on a like-for-like basis 2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum [...]

SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie

24/04/2025 - 18:00

SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie Fleurieux-sur-l’Arbresle - France - le 24 avril 2025 à 18h . Safe SA (la « Société ») est fière d'annoncer la [...]

Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million

24/04/2025 - 18:00

Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million Halle (Saale) / Munich, Germany, April 24, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (“ Vivoryon ” or the “ [...]

Nerve Renew Under Review & Ingredients Guide | Best Nerve Pain Supplement Explained

24/04/2025 - 13:52

Nerve Renew is a dietary supplement formulated to support nerve health, particularly for individuals experiencing symptoms of peripheral neuropathy such as tingling, numbness, burning sensations, or nerve pain Eagle, [...]

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

24/04/2025 - 13:55

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa monkeypox virus Durability of TNX-801 [...]

ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative R&D Trends for Inflammasome Inhibitors, and Provides Update on Inflammasome ASC Inhibitor IC 100’s Development Status

24/04/2025 - 13:57

WESTON, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with [...]

ORYZON Raises €30 Million in Capital Increase

24/04/2025 - 14:00

Issued 12,765,958 new shares Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP Strong investor demand, with the offering significantly oversubscribed €15 million anchored by a leading US [...]

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

24/04/2025 - 14:00

ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today [...]

Autonomize AI Prior Authorization Copilot: Helping Patients Get Care Faster, Safer, and with Less Stress

24/04/2025 - 14:00

AUSTIN, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Autonomize AI, the leader in healthcare-native AI, today announced a major update to its Prior Authorization Copilot that is delivering rapid, patient-centered [...]

Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data

24/04/2025 - 14:00

April 28 th AUA data presentation to highlight study in patients with high-grade non-muscle invasive bladder cancer (HG-NMIBC) Virtual event to be held on April 28, 2025 at 4:30 PM ET CORAL GABLES, Fla., April 24, 2025 [...]

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

24/04/2025 - 14:00

>8,500 samples and 100 million cells of high resolution and fully annotated spatial proteomics data available MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial [...]

X4 Pharmaceuticals Announces Reverse Stock Split

24/04/2025 - 14:00

BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of directors has [...]

Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting

24/04/2025 - 14:00

CUPERTINO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025

24/04/2025 - 14:00

TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. [...]